News Releases
Sep 22 2004
Peregrine Pharmaceuticals, Inc. Submits IND for Its Novel Anti-Cancer Agent Tarvacin(TM)
Sep 1 2004
Peregrine Pharmaceuticals Extends its Platform of Novel Anti-Cancer Technologies
Aug 2 2004
Peregrine Pharmaceuticals Announces Patient Enrollment Completion for Cotara(TM) Phase I Study for Colorectal Cancer
Jul 6 2004
Peregrine Pharmaceuticals Licenses Additional Intellectual Property for Its Anti-Phospholipid Therapy Platform Technology
Jun 28 2004
Peregrine Pharmaceuticals Announces Patent Grants for Vascular Targeting Agents
Jun 24 2004
Affitech AS and Peregrine Pharmaceuticals Announce Research Milestone Achievement by Affitech
May 19 2004
Peregrine Pharmaceuticals Announces Patent Grant for Vasopermeation Enhancement Technology
May 19 2004
Peregrine Pharmaceuticals to Present at the UBS Global Specialty Pharmaceuticals Conference
May 18 2004
Review of Peregrine's Anti-VEGF Technology Presented at Third Annual Angiogenesis Conference
May 18 2004
Review of Peregrine's Anti-Phospholipid Therapy Program Presented at Second International Conference on Vascular Targeting